Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1–Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial

出版年份 2017 全文链接

标题

作者

关键词

出版物

Volume 35, Issue 36, Pages 4035-4041

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2017-11-03

DOI

10.1200/jco.2017.74.5471

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now